BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30450853)

  • 1. Ophthalmoplegia in Mitochondrial Disease.
    Lee SJ; Na JH; Han J; Lee YM
    Yonsei Med J; 2018 Dec; 59(10):1190-1196. PubMed ID: 30450853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical, myopathological, and genetic analysis of 155 Chinese mitochondrial ophthalmoplegia patients with mitochondrial DNA single large deletions.
    Zhao Y; Hou Y; Zhao X; Liufu T; Yu M; Zhang W; Xie Z; Zhang VW; Yuan Y; Wang Z
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2328. PubMed ID: 38018320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
    Wang ZX; Yuan Y; Gao F; Qi Y; Shen DG; Chen QT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):273-8. PubMed ID: 12903032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation.
    Isashiki Y; Nakagawa M; Ohba N; Kamimura K; Sakoda Y; Higuchi I; Izumo S; Osame M
    Acta Ophthalmol Scand; 1998 Feb; 76(1):6-13. PubMed ID: 9541428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].
    Barrientos A; Casademont J; Grau JM; Cardellach F; Montoya J; Estivill X; Urbano-Márquez A; Nunes V
    Med Clin (Barc); 1995 Jul; 105(5):180-4. PubMed ID: 7630231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].
    Wabbels B; Ali N; Kunz WS; Roggenkämper P; Kornblum C
    Ophthalmologe; 2008 Jun; 105(6):550-6. PubMed ID: 18373100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome?
    Poulton J; Morten KJ; Weber K; Brown GK; Bindoff L
    Hum Mol Genet; 1994 Jun; 3(6):947-51. PubMed ID: 7951243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of Kearns-Sayre syndrome].
    Kokot W; Iwaszkiewicz-Bilikiewiczowa B; Lewczuk A; Sworczak K
    Klin Oczna; 1996; 98(4):327-30. PubMed ID: 9463130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular mitochondrial myopathies: a spectrum of clinical presentations].
    Glutz von Blotzheim S; Borruat FX; Hirt L
    Klin Monbl Augenheilkd; 1998 May; 212(5):299-300. PubMed ID: 9677561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA deletion, brain MRI and electrophysiological studies].
    Nakagawa M; Tokimura M; Kuriyama M; Higuchi I; Osame M
    Rinsho Shinkeigaku; 1991 Sep; 31(9):981-6. PubMed ID: 1769162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA.
    Zoccolella S; Torraco A; Amati A; Lamberti P; Serlenga L; Papa S; Petruzzella V
    Funct Neurol; 2006; 21(1):39-41. PubMed ID: 16735000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion.
    Grigalionienė K; Burnytė B; Balkelienė D; Ambrozaitytė L; Utkus A
    Mol Genet Genomic Med; 2023 Jan; 11(1):e2059. PubMed ID: 36181358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
    Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
    J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exophthalmos in Kearns-Sayre syndrome.
    Tauber J; Polla DJ; Park S
    J AAPOS; 2019 Oct; 23(5):295-297. PubMed ID: 31158487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples.
    De Coo IF; Gussinklo T; Arts PJ; Van Oost BA; Smeets HJ
    J Neurol Sci; 1997 Jul; 149(1):37-40. PubMed ID: 9168163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?
    Auré K; Ogier de Baulny H; Laforêt P; Jardel C; Eymard B; Lombès A
    Brain; 2007 Jun; 130(Pt 6):1516-24. PubMed ID: 17439982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia.
    Pfeffer G; Sirrs S; Wade NK; Mezei MM
    Can J Neurol Sci; 2011 Jan; 38(1):119-23. PubMed ID: 21156440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KEARNS-SAYRE SYNDROME MASQUERADING AS MYASTHENIA GRAVIS.
    Sokol JT; Hoyek S; Fulton AB; Patel NA
    Retin Cases Brief Rep; 2024 May; 18(3):396-399. PubMed ID: 36729003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.
    Bosbach S; Kornblum C; Schröder R; Wagner M
    Brain; 2003 May; 126(Pt 5):1231-40. PubMed ID: 12690061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.